期刊文献+

沙立度胺对乳腺癌细胞血管内皮生长因子表达的影响 被引量:2

Effect of thalidomide on the expression of VEGF mRNA in human breast cancer cell lines
原文传递
导出
摘要 目的观察沙立度胺对人乳腺癌细胞系MCF-7、MDA-MB-231细胞血管内皮生长因子(VEGF)表达的抑制作用。方法应用半定量逆转录-聚合酶链反应(RT—PCR)技术,分别观察沙立度胺对MCF-7和MDA-MB-231细胞VEGF表达的抑制作用。结果沙立度胺在50μg/L明显抑制两株细胞VEGF mRNA的表达,但浓度增高到100μg/L抑制VEGF mRNA表达的作用反而减弱。结论沙立度胺在一定浓度范围内能抑制乳腺癌细胞VEGF mRNA的表达。 Objective To assess the effects of thalidomide on VEGF mRNA level in human breast cancer cell lines. Methods Breast cancer cells were treated with thalidomide for 24-72h, RT-PCR was uced to detect the level of VEGF mRNA expression. Results When the concentration of drug is 50μg/L,thalidomide strongly inhibited the level of VEGF mRNA expression. Conclusion Within certain concentration range of thalidomide can inhibit the level of VEGF mRNA expression in breast cancer cell.
出处 《中国基层医药》 CAS 2008年第7期1057-1058,1233,共3页 Chinese Journal of Primary Medicine and Pharmacy
基金 河北省科技攻关项目(062761401)
关键词 乳腺肿瘤 沙立度胺 血管内皮生长因子 细胞系 Breast neoplasm Thalidomide Vascular endothelial growth factor Cell lines
  • 相关文献

参考文献5

  • 1Guo P, Fang Q, Tao HQ, et al. Over expression of vascular endothelial growth factor by MCF-7 breast cancer cells promotes estrogen-independent humor growth in vlvo. Cancer Res, 2003,63 (15) :4684-4691.
  • 2段永强,余辉,王钢胜,吴继权,陈援浩.肺癌患者血管内皮生长因子表达与预后的关系[J].中国基层医药,2006,13(10):1591-1592. 被引量:5
  • 3Mingqing S, Sreemathy R, Sumathi R, et al. Angiogenic role for glycodelin in tumorigenesis. Medical Sciences, 2001, 98 ( 16 ) : 9265-9270.
  • 4Mukhopadhyay D, Tslokas L, Sukhatrne VP. Wild-type p53 and v-Src exert opposing influences on human vascular endothelial growth factor gene expression. Cancer Research, 1999,55 (24) : 6161-6165.
  • 5李西平,王洁,刘叙仪,王曾礼,蒋薇,张毅,刘元林.反应停对人类肺腺癌细胞系血管内皮生长因子表达影响[J].天津医药,2002,30(10):608-611. 被引量:4

二级参考文献20

  • 1邓靖宇,何生.血管内皮生长因子和内皮抑素在肝癌抗肿瘤相关血管治疗中的作用[J].中华肝脏病杂志,2005,13(4):313-314. 被引量:8
  • 2谢忠,林翔,冯华扬,谢杰荣,温继育,冯丽萍.胃癌组织中血管内皮生长因子和基质金属蛋白酶-9的表达及相关性研究[J].中国基层医药,2005,12(12):1670-1672. 被引量:3
  • 3[1]Slodkowska J, Sikora J, Roszkowski-Sliz K, et al. Expression of vascular endothelial growth factor and basic fibroblast growth factor receptors in lung cancer. Anal Quant Cytol Histol, 2000, 22: 398~402.
  • 4[2]Kebel RS. Tumor angiogenesis: past, present and the near fu ture. Carcinogenesis, 2000, 21(3): 505~15.
  • 5[3]D' Amato RJ, Loughman MS, Flynn E.Thalidomide is an inhibitor of angiogenesis. Proc Natl Acad Sci USA, 1994, 91: 4082~5.
  • 6[4]Folkman J.Tumor angiogenesis: Therapeutic implications. N Engl J Med, 1971, 285: 1182~6.
  • 7[5]Minchinton AI, Fryer KH, Wendt KR, et al. The effect of thalidomide on experimental tumors and metastases. Anticancer Drugs, 1996, 7: 339~43.
  • 8[6]Hideshima T, Chauhan D, Shima Y, et al. Thalidomide and tis analogs overcome drug resistance of human multiple myeloma cells to conventional therapy. Blood, 2000, 96: 2943~ 50.
  • 9[7]Rajkumar SV, Fonseca R, Dispenzieri A, et al. Thalidomide in the treatment of relapsed multiple mye1oma. Mayo Clin Proc, 2000, 89: 488~ 99.
  • 10[8]Singhal S, Mehta J, Desikan R, et al.Antitumor activity of thalidomide in refractory multiple myeloma. N Engl J Med, 2000, 342: 344.

共引文献7

同被引文献17

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部